AGC
CVS icon

Aspen Grove Capital’s CVS Health CVS Stock Holding History

Aspen Grove Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,076
Closed -$245K – 209
2024
Q1 		$245K Buy
3,076
+91
+3% +$6.95K 0.07% 165
2023
Q4 		$236K Buy
+2,985
New +$212K 0.07% 154
2023
Q3 		– Sell
-3,946
Closed -$273K – 185
2023
Q2 		$273K Buy
+3,946
New +$281K 0.09% 152
2023
Q1 		– Sell
-2,151
Closed -$200K – 161
2022
Q4 		$200K Buy
+2,151
New +$208K 0.09% 147

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Aspen Grove Capital's CVS Position: Q2 2024 in Review

Aspen Grove Capital sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,076 shares — an estimated $245K sold.

Aspen Grove Capital first reported a position in CVS in Q4 2022 and held it in 4 quarters. The position peaked at $273K in Q2 2023. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Aspen Grove Capital reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Aspen Grove Capital sold 3,076 CVS Health shares in Q2 2024, an estimated $245K.
  • Aspen Grove Capital first reported a position in CVS Health in Q4 2022 and held it in 4 quarters.
  • Aspen Grove Capital's CVS Health position peaked at $273K in Q2 2023.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Aspen Grove Capital's 13F filing for Q2 2024, filed 14 Aug 2024.